|
Title
|
|
|
|
Importance of heterogeneity in bariatric surgery candidates : comment on: Psychiatric medication use and weight outcomes one year after bariatric surgery. Hawkins et al. , Psychosomatics Volume 61, Issue 1, 2020; Pages 56-63
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| With growing obesity rates, an increasing number of bariatric procedures are performed every year. A large number of these patients are treated with psychotropic drugs such as antidepressants, antipsychotics or benzodiazepines. Although not every psychotropic drug affects the body weight, weight gain and weight loss are often described as a side effect of some of these medications. Recently, the article entitled “Psychiatric Medication Use and Weight Outcomes One Year After Bariatric Surgery” was published by Hawkins et al. which demonstrated no negative impact of psychotropic drugs on weight loss after a gastric bypass procedure. However, earlier in 2019 and opposite to these results, our group already reported a significant effect of some classes of antidepressants on weight outcomes after bariatric surgery. In this letter to the editor, we comment on the differences between both studies and how heterogeneity between patients and sample size limitations could have attributed to the apparently conflicting results. Furthermore, we propose an international, multi-center collaboration to investigate the effectiveness, safety, and impact of psychotropic drugs after bariatric surgery. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Psychosomatics. - Washington, D.C.
| |
|
Publication
|
|
|
|
Washington, D.C.
:
2020
| |
|
ISSN
|
|
|
|
0033-3182
| |
|
DOI
|
|
|
|
10.1016/J.PSYM.2020.04.016
| |
|
Volume/pages
|
|
|
|
61
:6
(2020)
, p. 860-861
| |
|
ISI
|
|
|
|
000590897400050
| |
|
Pubmed ID
|
|
|
|
32487322
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|